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Abstract To investigate the molecular events controlling
myelination of the peripheral nervous system, we compared gene
expression of normal mouse sciatic nerves to that of the trembler
mouse, whose Schwann cells are blocked in a pre-myelinating
phenotype. Using cDNA array, we assessed expression levels of
1176 genes, and we found that delta-like protein (dlk), an
epidermal growth factor-like homeotic protein, was expressed
in the normal developing nerves, but at a low level in the
dysmyelinating mutant trembler. Moreover, dlk expression was
down-regulated when myelin protein expression was up-regu-
lated, and no expression was observed in the developing brain.
These results suggest that dlk expression is required for Schwann
cell acquisition of the myelinating phenotype. ß 2001 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
In the immature, developing peripheral nerve, a large bun-
dle of naked axons becomes encompassed by a single layer of
Schwann cells. The establishment of axonal contact triggers
Schwann cell proliferation [1,2]. These axons are gradually
segregated as the Schwann cells proliferate, and a one-to-
one relationship is established between each Schwann cell
and the isolated axonal segment to be myelinated [3]. There-
after, Schwann cells progress from this pre-myelinating phe-
notype toward a myelinating one. This transition occurs in the
¢rst week of postnatal life in the rodent sciatic nerve, and
depends upon changes in expression of a whole network of
genes. Indeed, peripheral nervous system (PNS) myelin^pro-
tein genes are up-regulated, along with several genes encoding
enzymes involved in myelin^lipid biosynthesis, and immature
Schwann cell genes are down-regulated. This regulation at the
level of gene expression involves transcription factors. Among
these, Oct-6, Krox-20, and Sox-10 have been shown to par-
ticipate in the development of the myelinating phenotype of
the Schwann cell [4]. Nevertheless, despite extensive studies,
the nature of the axonal signals that initiate the myelination
process remains elusive. It is most likely that this signal is at
least partially mediated by receptors on both the axonal and
the Schwann cell membranes, but these molecules have not yet
been identi¢ed.
In an attempt to identify new genes that are involved in the
progression of the Schwann cells from a pre-myelinating to-
ward a myelinating phenotype, we compared the patterns of
gene expression in normal and trembler mutant mouse nerves.
The autosomal dominant trembler mutation, which a¡ects the
peripheral myelin protein of 22 kDa (PMP22) gene, results in
an abnormal myelination of the PNS [5]. Indeed, a conse-
quence of this mutation is that the di¡erentiating Schwann
cells attain a one-to-one relationship with the axons, but do
not progress further towards a myelinating phenotype [6].
Using large-scale cDNA microarrays and Northern blot anal-
yses, we found that the expression of the epidermal growth
factor (EGF)-like protein delta-like protein (dlk) may play an
important role in Schwann cell di¡erentiation.
2. Materials and methods
2.1. Animals
Normal and heterozygous trembler mice were bred in our Univer-
sity’s animal facility. They were on the C57Black background.
2.2. RNA isolation
The mice were sacri¢ced by cervical rupture at the ages of 5^50
days postnatal. Sciatic nerves from 10^15 age-matched animals were
pooled, and RNA was isolated using the guanidinium isothiocyanate/
cesium chloride procedure [7]. The integrity of RNAs was assessed by
analyzing 18S and 28S ribosomal RNA.
2.3. cDNA array procedures and analyses
Samples of total RNA (5 Wg) were used to synthesize [K-32P]dATP
cDNA probes for hybridization according to the manufacturer’s pro-
tocol (Clontech, Palo Alto, CA, USA). The 32P-labeled cDNA probes
were further puri¢ed by column chromatography (NucTrap0 Probe
puri¢cation Column, Stratagene, CA, USA). The Atlas Mouse 1.2
Array, containing 1176 mouse cDNAs, was purchased from Clontech
(Palo Alto, CA, USA). The di¡erent probes (3.106 cpm/ml) were hy-
bridized overnight (68‡C) on separate ¢lter arrays, and washed ac-
cording to the manufacturer’s instructions. After exposure to a Phos-
phorImager screen (Molecular Dynamics) for 2^4 days, the images
were analyzed using the ImageQuaNT software (Molecular Dynam-
ics).
After subtraction of the background, signal values were normalized
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by dividing by the mean ¢lter hybridization signal (the expression
levels for the majority of the genes remain unchanged between normal
and trembler samples). No signals were detected in the spots of plas-
mid or bacteriophage DNAs, thus con¢rming the speci¢city of the
hybridization. Four independent experiments were performed with
normal samples and two with trembler samples. For each gene
studied, the ratio was calculated by dividing the average value ob-
tained for the normal samples (n = 4) by the average value of the
trembler samples (n = 2).
2.4. Northern blot analysis
The RNA samples were separated in a 1.2% agarose/3% formalde-
hyde baby gel, transferred to Hybond-N membranes (Amersham Bio-
sciences) in a solution of 20U SSPE, cross-linked to the membrane by
UV irradiation (UV Stratalinker 1800, Stratagene, La Jolla, CA,
USA) and pre-hybridizations and hybridizations were then carried
out using ULTRAhyb solution (Ambion, Austin, TX, USA). Labeling
of cDNA probes to a speci¢c activity of 5U108 to 2U109 cpm/Wg was
done using a Prime-it II random primer labeling kit (Stratagene). The
membranes were exposed in a PhosphorImager cassette, and signals
were quanti¢ed using ImageQuaNT Software (Molecular Dynamics).
The human glyceraldehyde 3-phosphate dehydrogenase cDNA probe
was purchased from Clontech. The mouse dlk cDNA fragment was
obtained by the RT-PCR technique using normal sciatic nerves cDNA
(15 days old), and the following primers (5P^3P) : dlk forward, TTC
TCT GGA AAG GAC TGC CA, and dlk reverse, AGA GGG GTA
CTC TTG TTG AG. The sequences of the primers were chosen from
the published sequences of the mouse dlk cDNA [8].
3. Results and discussion
3.1. cDNA arrays
Four distinct RNA samples obtained from 15-day-old nor-
mal mouse sciatic nerves and two distinct samples from trem-
bler nerves were used to prepare 32P-labeled cDNA probes,
which were then hybridized to individual Atlas Mouse 1.2
Arrays Clontech containing cDNAs for 1176 mouse genes.
Of the 1176 genes, around 800 gave a signal above the back-
ground value in both types of mice. Approximately 150 genes
gave signals above the average hybridization value, and 80
gave a signal above two-fold the average, i.e. around 7% of
the 1176 genes studied were expressed at a high level in the
sciatic nerves of the trembler and normal mice.
25 genes displayed a di¡erential expression pattern between
the control and mutant samples, but only 12 met the required
criteria, i.e. they were signi¢cantly expressed in normal or
trembler samples (expression level twice that of the average
hybridization value), and were di¡erentially expressed by a
factor greater than 2.5 (Table 1). In total, eight genes were
predominantly expressed in the mutant nerves and four in the
normal ones.
Among the eight genes expressed in the mutant nerves,
three are involved in protein turnover. Cathepsin D is a lyso-
somal aspartic endopeptidase which is known to be up-regu-
lated during nerve injury [9,10]. Tissue inhibitor of metallo-
proteinase 3, a protein which regulates extracellular matrix
degradation, plays a role in developmental patterning and in
the maintenance of speci¢c di¡erentiated tissue. It is over-ex-
pressed in a variety of degenerative retinopathies [11^13]. Pro-
tease nexin 1, a potent inhibitor of serine proteases, is up-
regulated following peripheral nerve lesion [14]. The over-ex-
pression of this gene leads to progressive neuronal and motor
dysfunction [15]. Two other genes corresponded to the heat
shock 86-kDa and 84-kDa proteins, ¢rstly identi¢ed as tumor-
speci¢c transplantation antigens, which form in vivo the 90-
kDa heat shock protein complex [16^18]. We also identi¢ed
two transcription factors whose expressions are elevated in the
mutant nerves. The ¢rst was T-box protein 2, a DNA-binding
protein that regulates gene expression during embryogenesis
[19] and which is highly expressed in primary human breast
cancers [20,21]. The second was a member of the signal trans-
ducer and activators of transcription (STAT) gene family that
are the main mediators in the signal transduction pathways of
cytokines. STAT 3 expression has been demonstrated after
peripheral nerve injury [22], but this is the ¢rst time that the
expression of STAT 1 is reported for a peripheral neuropathy.
Finally, the last gene encodes the G1/S-speci¢c cyclin D1,
which plays a role in the control of cell proliferation, and
which was shown to control the mitotic response of Schwann
cells in the Wallerian degeneration model of nerve injury
[23,24]. In summary, the eight genes over-expressed in the
trembler nerve encode proteins which are known to be impli-
cated in abnormal cell proliferation and/or peripheral nerve
degeneration, two processes which take place in the trembler
PNS [6].
Four genes were predominantly expressed in normal sciatic
nerves. As expected, we found the genes encoding the myelin
protein zero (P0) and PMP22, whose under-expression in the
trembler nerves has been already reported [25,26]. Moreover,
the normal/trembler ratios measured in the present study for
15-day-old animals, which were 7.4 for PMP22 and 2.6 for P0,
were similar to those previously measured by the Northern
blot technique, which were 11 for PMP22 and 3.9 for P0
[26]. This ¢nding validates our screening approach. The third
gene encodes the insulin-like growth factor 2. It has previously
been shown that this factor supports motoneuron survival,
and that it regulates both Schwann cell proliferation and dif-
Table 1
Genes di¡erentially expressed in 15-day-old normal and trembler sciatic nerves
GenBank accession # Gene/protein name Normal/trembler ratioa
M32240 PMP22 7.4
L12721 dlk 6.0
M14951 Insulin-like growth factor 2 4.2
M62860 P0 2.6
X70296 Protease nexin 1 0.4
X53337 Cathepsin D 0.32
U06924 STAT 1 0.24
L19622 Tissue inhibitor of metalloproteinase 3 0.21
M36829 Heat shock 84-kDa protein 0.18
M36830 Heat shock 86-kDa protein 0.17
S78355 G1/S-speci¢c cyclin D1 0.16
U15566 T-box protein 2 0.12
aRatios were calculated by dividing the average value obtained for the normal samples (n = 4) by the average value of the trembler samples
(n = 2).
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ferentiation during nerve regeneration [27^30]. Finally, the
most interesting ¢nding is that the gene encoding the dlk,
also known as pre-adipocyte factor 1 or adipocyte di¡erentia-
tion inhibitor protein, is predominantly expressed in the nor-
mal nerve. This homeotic protein possesses six EGF-like se-
quences at the extracellular domain, a single transmembrane
domain and a short intracellular tail [31]. The EGF-like mo-
tifs are highly homologous to the EGF-like motifs of the
Drosophila homeotic protein Delta, a ligand for the Notch
receptor. This homeotic protein is involved in several di¡er-
entiation processes such as adipogenesis, hematopoiesis and
neuroendocrine di¡erentiation [31].
3.2. Expression of dlk
The expression of dlk was further studied using the North-
ern blot technique. From the blot shown in Fig. 1A, we cal-
culated a normal/trembler ratio of 7, which is to be compared
to the ratio of 6 obtained by the cDNA arrays approach,
con¢rming again the reliability of the method used. The de-
velopmental expression of dlk mRNA in normal nerve is
shown in Fig. 1B. The highest level was measured 5 days after
birth. dlk mRNA steady-state levels then gradually declined
during the next days to become undetectable at postnatal day
30. Indeed, dlk mRNA expression was inversely correlated to
P0 mRNAs expression during sciatic nerve development (Fig.
1C). In addition, the postnatal expression of dlk in the ner-
vous system is speci¢c for the PNS, because the corresponding
transcript was not detected in the developing mouse brain
during the ¢rst weeks of life, a period when central nervous
system myelination is initiated (Fig. 2).
3.3. Possible role of dlk during PNS development
dlk has been reported to play an important role during
adipocyte di¡erentiation. The corresponding gene is highly
expressed upon induction of di¡erentiation in primary rat
pre-adipocytes during the ¢rst 2 days of the di¡erentiation
process. The expression then diminishes during the course of
di¡erentiation, and dlk expression is not detected in fully dif-
ferentiated adipocytes [32,33]. This down-regulation of dlk is
needed for complete adipocyte di¡erentiation, because consti-
tutive expression of dlk inhibits adipogenesis [34].
Our results showed that the regulation of dlk expression in
the nervous system is myelination-related and PNS-speci¢c. In
the peripheral nerve, dlk expression is observed during the
early stages of myelinogenesis and is down-regulated once
the process is under way, when the genes of the major myelin
structural proteins are up-regulated in normal nerves. More-
over, dlk expression is severely reduced in the nerves of the
dysmyelinating mutant trembler mouse, in which the terminal
di¡erentiation towards a myelinating phenotype is initiated,
but blocked at the promyelin stage. Finally, dlk was highly
expressed in the developing peripheral nerve, but not in the
brain. These results suggest that, as for the adipocytes, dlk
expression may be required during the initial stages of
Schwann cell di¡erentiation towards a myelinating phenotype,
and that its down-regulation could be important in allowing
the completion of the myelination program. To investigate
further the role of dlk in the myelination process, retroviral
Fig. 1. dlk mRNA expression in mouse sciatic nerves. 5 Wg of total
RNA were applied to an agarose/formaldehyde gel, blotted and hy-
bridized successively with the dlk and glyceraldehyde 3-phosphate
dehydrogenase (gapdh) cDNA probes. A: 15-Day-old normal and
trembler samples. B: Samples from normal mouse sciatic nerves. C:
dlk and P0 mRNA levels during postnatal development of the
mouse sciatic nerve. After correction for RNA levels between lanes
using the gapdh results, quantitations were performed using a Phos-
phorImager. Results are presented as the percentage of the maximal
level measured during the developmental period studied. Data are
mean values of two experiments for dlk and mean þ S.E.M. (bars)
values of ¢ve experiments for P0.
Fig. 2. dlk mRNA in the developing brain and sciatic nerve. 5 Wg
(sciatic nerve) and 20 Wg (brain) of total RNA were applied to an
agarose/formaldehyde gel, blotted and hybridized successively with
the dlk and glyceraldehyde 3-phosphate dehydrogenase (gapdh)
cDNA probes. Lanes are marked according to postnatal age.
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vector-infected mouse Schwann cells expressing either sense or
antisense dlk mRNAs will be engineered, and their capacity to
di¡erentiate into myelin forming cells will be evaluated.
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